133 related articles for article (PubMed ID: 20649681)
1. Neutrophil and monocyte activation in chronic kidney disease patients under hemodialysis and its relationship with resistance to recombinant human erythropoietin and to the hemodialysis procedure.
Pereira R; Costa E; Gonçalves M; Miranda V; do Sameiro Faria M; Quintanilha A; Belo L; Lima M; Santos-Silva A
Hemodial Int; 2010 Jul; 14(3):295-301. PubMed ID: 20649681
[TBL] [Abstract][Full Text] [Related]
2. Neutrophil activation and resistance to recombinant human erythropoietin therapy in hemodialysis patients.
Costa E; Rocha S; Rocha-Pereira P; Nascimento H; Castro E; Miranda V; Faria Mdo S; Loureiro A; Quintanilha A; Belo L; Santos-Silva A
Am J Nephrol; 2008; 28(6):935-40. PubMed ID: 18587235
[TBL] [Abstract][Full Text] [Related]
3. HLA-DR expression and apoptosis: a cross-sectional controlled study in hemodialysis and peritoneal dialysis patients.
de Cal M; Cruz DN; Corradi V; Nalesso F; Polanco N; Lentini P; Brendolan A; Tetta C; Ronco C
Blood Purif; 2008; 26(3):249-54. PubMed ID: 18376106
[TBL] [Abstract][Full Text] [Related]
4. Soluble P-selectin during a single hemodialysis session in patients with chronic renal failure and erythropoietin treatment.
Stasko J; Galajda P; Ivanková J; Hollý P; Rozborilová E; Kubisz P
Clin Appl Thromb Hemost; 2007 Oct; 13(4):410-5. PubMed ID: 17911193
[TBL] [Abstract][Full Text] [Related]
5. Acute and chronic influence of hemodialysis according to the membrane used on phagocytic function of neutrophils and monocytes and pro-inflammatory cytokines production in chronic renal failure patients.
Muniz-Junqueira MI; Braga Lopes C; Magalhães CA; Schleicher CC; Veiga JP
Life Sci; 2005 Nov; 77(25):3141-55. PubMed ID: 16005905
[TBL] [Abstract][Full Text] [Related]
6. Apoptosis of peripheral CD4(+) T-lymphocytes in end-stage renal disease patients under hemodialysis and rhEPO therapies.
Borges A; Borges M; Fernandes J; Nascimento H; Sameiro-Faria M; Miranda V; Reis F; Belo L; Costa E; Santos-Silva A
Ren Fail; 2011; 33(2):138-43. PubMed ID: 21332334
[TBL] [Abstract][Full Text] [Related]
7. Intracellular acidification enhances neutrophil phagocytosis in chronic haemodialysis patients: possible role of CD11b/CD18.
Lin CS; Wann JG; Hsiao CW; Tai DW; Chen JS; Hsu YH; Huang HC; Chao CF
Nephrol Dial Transplant; 2008 May; 23(5):1642-9. PubMed ID: 18065787
[TBL] [Abstract][Full Text] [Related]
8. Lymphocyte 5'-nucleotidase and aminopeptidase N activity in patients on maintenance hemodialysis treated with human recombinant erythropoietin and 1-alpha-D3.
Stefanovic V; Mitić-Zlatkovic M; Radivojevic J; Vlahovic P
Ren Fail; 2005; 27(3):283-8. PubMed ID: 15957544
[TBL] [Abstract][Full Text] [Related]
9. Long-term effects on lymphocytotoxic antibodies and immune reactivity in hemodialysis patients treated with recombinant human erythropoietin.
Bárány P; Fehrman I; Godoy C
Clin Nephrol; 1992 Feb; 37(2):90-6. PubMed ID: 1551255
[TBL] [Abstract][Full Text] [Related]
10. Effect of recombinant human erythropoietin on insulin resistance in hemodialysis patients.
Khedr E; El-Sharkawy M; Abdulwahab S; Eldin EN; Ali M; Youssif A; Ahmed B
Hemodial Int; 2009 Jul; 13(3):340-6. PubMed ID: 19552740
[TBL] [Abstract][Full Text] [Related]
11. 2008 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease.
Tsubakihara Y; Nishi S; Akiba T; Hirakata H; Iseki K; Kubota M; Kuriyama S; Komatsu Y; Suzuki M; Nakai S; Hattori M; Babazono T; Hiramatsu M; Yamamoto H; Bessho M; Akizawa T
Ther Apher Dial; 2010 Jun; 14(3):240-75. PubMed ID: 20609178
[TBL] [Abstract][Full Text] [Related]
12. Orally administrated Juzen-taiho-to/TJ-48 ameliorates erythropoietin (rHuEPO)-resistant anemia in patients on hemodialysis.
Nakamoto H; Mimura T; Honda N
Hemodial Int; 2008 Oct; 12 Suppl 2():S9-S14. PubMed ID: 18837771
[TBL] [Abstract][Full Text] [Related]
13. Red blood cell membrane lipid peroxidation and resistance to erythropoietin therapy in hemodialysis patients.
Gallucci MT; Lubrano R; Meloni C; Morosetti M; Manca di Villahermosa S; Scoppi P; Palombo G; Castello MA; Casciani CU
Clin Nephrol; 1999 Oct; 52(4):239-45. PubMed ID: 10543326
[TBL] [Abstract][Full Text] [Related]
14. Clinical and angiographic correlates of leukocyte activation in unstable angina.
De Servi S; Mazzone A; Ricevuti G; Mazzucchelli I; Fossati G; Gritti D; Angoli L; Specchia G
J Am Coll Cardiol; 1995 Nov; 26(5):1146-50. PubMed ID: 7594025
[TBL] [Abstract][Full Text] [Related]
15. Post-reperfusion changes of monocyte function in coronary blood after extracorporeal circulation.
Sbrana S; Bevilacqua S; Buffa M; Spiller D; Parri MS; Gianetti J; De Filippis R; Clerico A
Cytometry B Clin Cytom; 2005 May; 65(1):14-21. PubMed ID: 15786508
[TBL] [Abstract][Full Text] [Related]
16. Determinants of soluble CD23 antigen levels in hemodialysis patients: effect of 1.25 dihydroxyvitamin D3 and recombinant human erythropoietin treatment.
Altun B; Erdem Y; Usalan C; Arici M; Haznedaroglu IC; Yasavul U; Turgan C; Caglar S; Kirazli S
Clin Nephrol; 1999 Oct; 52(4):230-8. PubMed ID: 10543325
[TBL] [Abstract][Full Text] [Related]
17. Monocyte expression of adhesion molecules during low- and high-flux polysulfone hemodialysis and the effect of atorvastatin administration.
Stavroulopoulos A; Petras D; Kakavas I; Agroyannis I; Stamatelou K; Vyssoulis G; Papadakis IT; Stefanadis C
Blood Purif; 2010; 29(3):274-9. PubMed ID: 20068293
[TBL] [Abstract][Full Text] [Related]
18. Modulation of human leukocyte antigen-DR on monocytes and CD16 on granulocytes in patients with septic shock using hemoperfusion with polymyxin B-immobilized fiber.
Ono S; Tsujimoto H; Matsumoto A; Ikuta S; Kinoshita M; Mochizuki H
Am J Surg; 2004 Aug; 188(2):150-6. PubMed ID: 15249240
[TBL] [Abstract][Full Text] [Related]
19. Recombinant human erythropoietin resistance in hemodialysis. Effects of paired filtration dialysis.
Carozzi S; Nasini MG; Santoni O; Tirotta A; Sanna A
ASAIO J; 1997; 43(5):M535-8. PubMed ID: 9360100
[TBL] [Abstract][Full Text] [Related]
20. [Retardation of hemodialysis by recombinant human erythropoietin in patients with chronic kidney disease].
Kato F; Takeuchi N; Takenoshita E; Yuasa J; Isaka S; Fujii T; Suzuki S; Irie Y; Ogawa M; Ueda S
Nihon Jinzo Gakkai Shi; 2010; 52(1):58-65. PubMed ID: 20166543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
